Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Insulin Resistance × Metformin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2 Head & Neck 2 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 36 Triple Negative Breast Neoplasms 3 Obesity 3 Lung Neoplasms 3 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Kidney Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Breast Cancer Female 2 Brain Neoplasms 2 Weight Loss 1 Waldenstrom Macroglobulinemia 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Sezary Syndrome 1 Rectal Neoplasms 1 Racism 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Metformin 1 Insulin 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741204 2023-07-06

METBC

Woman's

Phase 4 Withdrawn

Breast Neoplasms, Insulin Resistance, Racism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡